Literature DB >> 19745686

Management of Bacillus bacteremia: the need for catheter removal.

Rawan Kassar1, Ray Hachem, Ying Jiang, Anne-Marie Chaftari, Issam Raad.   

Abstract

Bacillus species are biofilm-forming organisms that are associated with Bacillus catheter-related bloodstream infections (CRBSIs). The optimal treatment of Bacillus CRBSIs is not known. Therefore, in the current study, we determined the role of long-term central venous catheter (CVC) removal and treatment with vancomycin compared with other agents in Bacillus CRBSIs by retrospectively reviewing the medical records of cancer patients with Bacillus bacteremia who had been treated at our institution from December 1990 to March 2008. True bacteremia was defined as a positive blood culture (>15 colony-forming units/mL) with signs and symptoms of infection (such as fever and chills). Bacillus CRBSI was defined in accordance with the Infectious Diseases Society of America guidelines as probable or definite. There were 94 Bacillus bacteremia episodes, 93 of which (99%) were Bacillus CRBSIs (28% definite and 71% probable). Neutropenia during bacteremia occurred in 29%. Almost all bacteremia patients (99%) had been treated with antibiotics; 63% had received vancomycin. Sepsis with hypotension occurred in 6%, and endocarditis in 1%. Bacillus isolates were susceptible to linezolid (100%), vancomycin (98%), tetracycline (77%), and rifampin (67%). All 4 recurrences occurred in patients in whom the CVC had not been removed (12%), whereas no recurrences occurred in patients whose CVC had been removed (p = 0.028). Patient outcome, in terms of fever and hospitalization duration after the infection, was similar in patients who had received < or =10 days of systemic antibiotics compared with patients who had received >10 days. In conclusion, catheter retention in patients with Bacillus CRBSIs is associated with a significantly higher recurrence rate. If the CVC is retained, treatment with non-vancomycin antibiotics is associated with significantly shorter hospitalization duration after the infection, which may be because glycopeptide antibiotics have poor activity against bacilli embedded in biofilm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745686     DOI: 10.1097/MD.0b013e3181b7c64a

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  11 in total

1.  Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.

Authors:  Jae-Hoon Ko; Cheol-In Kang; Woo Joo Lee; Kyungmin Huh; Jeong Rae Yoo; Kwangmin Kim; Sun Young Cho; Young Eun Ha; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck; Jae-Hoon Song
Journal:  Support Care Cancer       Date:  2014-08-12       Impact factor: 3.603

Review 2.  Central Venous Access Device-Related Bacillus Cereus Endocarditis: A Case Report and Review of the Literature.

Authors:  William F Wright
Journal:  Clin Med Res       Date:  2016-05-26

3.  Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.

Authors:  Issam Raad; Anne-Marie Chaftari; Ramia Zakhour; Mary Jordan; Zanaib Al Hamal; Ying Jiang; Ammar Yousif; Kumait Garoge; Victor Mulanovich; George M Viola; Soha Kanj; Egbert Pravinkumar; Joel Rosenblatt; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 4.  Emerging knowledge of regulatory roles of D-amino acids in bacteria.

Authors:  Felipe Cava; Hubert Lam; Miguel A de Pedro; Matthew K Waldor
Journal:  Cell Mol Life Sci       Date:  2010-12-14       Impact factor: 9.261

5.  Bacillus cereus catheter related bloodstream infection in a patient with acute lymphoblastic leukemia.

Authors:  N Gurler; L Oksuz; M Muftuoglu; Fd Sargin; Sk Besisik
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-01-18       Impact factor: 2.576

6.  Current strategies for the prevention and management of central line-associated bloodstream infections.

Authors:  Zhuolin Han; Stephen Y Liang; Jonas Marschall
Journal:  Infect Drug Resist       Date:  2010-11-23       Impact factor: 4.003

7.  Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.

Authors:  Mahoko Ikeda; Yuka Yagihara; Keita Tatsuno; Mitsuhiro Okazaki; Shu Okugawa; Kyoji Moriya
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-15       Impact factor: 3.944

8.  Bacillus cereus bacteraemia: comparison between haematologic and nonhaematologic patients.

Authors:  S Tusgul; G Prod'hom; L Senn; R Meuli; P-Y Bochud; S G Giulieri
Journal:  New Microbes New Infect       Date:  2016-11-17

9.  The effects of TGF-β1 on staphylococcus epidermidis biofilm formation in a tree shrew biomaterial-centered infection model.

Authors:  Yujie Lei; Yushan Xu; Peng Jing; Bingquan Xiang; Keda Che; Junting Shen; Minjie Ning; Ying Chen; Yunchao Huang
Journal:  Ann Transl Med       Date:  2021-01

10.  Bacterial contamination of lightproof covers for high-calorie infusion solutions in wards.

Authors:  Kengo Hosomi; Yuko Takasu; Yumiko Hisai; Sachiko Komaki; Hiroaki Otsuki; Kyoko Okimoto; Sachiko Omotani; Yasutoshi Hatsuda; Michiaki Myotoku
Journal:  Int J Med Sci       Date:  2021-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.